Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HaemInCor: Intramyocardial Haemorrhage in STEMI Patients
NCT03677466Completed
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Primary endpoint: Intramyocardial haemorrhage in primary STEMI measure at 2 days. Started Jan 2018; status: completed.
02
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03677466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677466.